搜尋
Sophia Genetics SA
SOPH添加自選
7.870USD
0.0000.00%
交易中 09/14, 14:36（美東）
669.96M總市值
虧損本益比TTM
關於 Sophia Genetics SA 公司
SOPHiA GENETICS SA is a Switzerland-based company primarily engaged in the healthcare technology industry. The Company’s key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The Company has offices in Switzerland, France, and the United States and operates worldwide.
Sophia Genetics SA 簡介
公司代碼SOPH
公司名稱Sophia Genetics SA
上市日期Jul 23, 2021
CEOCamblong (Jurgi)
員工數量423
證券類型Ordinary Share
年結日Jul 23
公司地址La Piece 12
城市ROLLE
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Switzerland
郵編CH-1180
電話41216941060
網址https://www.sophiagenetics.com/
公司代碼SOPH
上市日期Jul 23, 2021
CEOCamblong (Jurgi)
Sophia Genetics SA公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Executive Chairman of the Board, Co-Founder
Executive Chairman of the Board, Co-Founder
2.82M
-1.72%
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Executive Chairman of the Board, Co-Founder
Executive Chairman of the Board, Co-Founder
2.82M
-1.72%
Mr. Ross J. Muken
Mr. Ross J. Muken
Chief Executive Officer, Director
Chief Executive Officer, Director
615.78K
-1.60%
Mr. Ross J. Muken
Mr. Ross J. Muken
Chief Executive Officer, Director
Chief Executive Officer, Director
615.78K
-1.60%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
489.08K
+4.03%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
489.08K
+4.03%
Dr. Zhenyu Xu, Ph.D.
Dr. Zhenyu Xu, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
443.79K
-12.17%
Dr. Zhenyu Xu, Ph.D.
Dr. Zhenyu Xu, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
443.79K
-12.17%
Mr. Troy M. Cox
Mr. Troy M. Cox
Independent Director
Independent Director
294.96K
+6.69%
Mr. Troy M. Cox
Mr. Troy M. Cox
Independent Director
Independent Director
294.96K
+6.69%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Executive Chairman of the Board, Co-Founder
Executive Chairman of the Board, Co-Founder
2.82M
-1.72%
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Executive Chairman of the Board, Co-Founder
Executive Chairman of the Board, Co-Founder
2.82M
-1.72%
Mr. Ross J. Muken
Mr. Ross J. Muken
Chief Executive Officer, Director
Chief Executive Officer, Director
615.78K
-1.60%
Mr. Ross J. Muken
Mr. Ross J. Muken
Chief Executive Officer, Director
Chief Executive Officer, Director
615.78K
-1.60%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
489.08K
+4.03%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
489.08K
+4.03%
常見問題
Sophia Genetics SA的前五大股東是誰？
Sophia Genetics SA的前五大股東如下：Dr. Jurgi Camblong, Ph.D.
有多少機構持有Sophia Genetics SA(SOPH)的股份？
截至2026Q1，共有89家機構持有Sophia Genetics SA的股份，合計持有的股份價值約為27.73M，占公司總股份的38.63% 。與2025Q4相比，機構持股有所增加，增幅為-11894064.00。